Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

IGF-1 LR3 Research Review: Anabolic vs Metabolic Comparison

IGF-1 analogs differ not only in half-life but also in receptor selectivity and metabolic side-effect profiles. The following table compares IGF-1 LR3 against native IGF-1 and IGF-1 DES. The three most commonly used forms in anabolic research protocols. Native

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • IGF-1 analogs differ not only in half-life but also in receptor selectivity and metabolic side-effect profiles. The following table compares IGF-1 LR3 against native IGF-1 and IGF-1 DES. The three most commonly used forms in anabolic research protocols.
  • Native IGF-1
  • 10 minutes (free); 12–15 hours (bound)
  • High affinity to all IGFBPs
  • Moderate selectivity; significant insulin receptor cross-reactivity at high doses
  • Acute signaling studies; requires continuous infusion for sustained effects
  • Short half-life limits practical use in most protocols
  • IGF-1 LR3
  • 18–24 hours
  • Minimal IGFBP binding
  • High IGF-1R selectivity; reduced insulin receptor activation
  • Muscle hypertrophy, regeneration, satellite cell activation, once-daily dosing studies
  • Best choice for sustained anabolic signaling with simplified dosing
  • IGF-1 DES (1-3)
  • 20–30 minutes
  • Very high IGF-1R selectivity; negligible insulin receptor cross-reactivity
  • Local tissue studies; autocrine/paracrine signaling models
  • Short half-life but extreme potency; useful for localized effects